Network Penetration Testing for Biotech companies in New York City (NY)
Network Penetration Testing for Biotech Companies in New York City (NY)
Biotech companies in New York City and across New York State are prime targets for cybercriminals. Intellectual property, clinical trial data, genomic datasets, research models, and confidential partnership information are all highly valuable on the black market. Attackers use methods such as phishing, ransomware, password attacks, malware, and SQL injection to gain unauthorized access and quietly exfiltrate this data.
The financial impact is significant. In 2021, the median reported cost of a data breach reached $4.24M—and that figure only reflects incidents that were disclosed. For a New York biotech organization, the real cost can be much higher when you factor in FDA and HIPAA implications, delays in clinical programs, damage to investor confidence, and loss of competitive advantage.
To stay ahead of these threats, biotech firms need to regularly review, test, and upgrade their cybersecurity controls. That includes validating protections around lab networks, research environments, cloud platforms, and third-party integrations with CROs, universities, and hospital systems.
What Is Network Penetration Testing for Biotech?
Network penetration testing (net-pen testing) is a controlled, ethical hacking exercise where security professionals simulate real-world cyberattacks against your IT and OT infrastructure. For biotech companies in New York, this typically includes:
Corporate networks and remote access used by research teams and executives
Laboratory networks connecting instruments, LIMS, ELN, and automation systems
Cloud environments hosting genomic data, clinical applications, and collaboration platforms
VPNs and connectivity with hospitals, CROs, partners, and university research centers
The goal is to identify and exploit weaknesses before a real attacker does. Outcomes from a professional penetration test help leadership:
Understand true cyber risk to critical R&D, IP, and patient data
Verify the effectiveness of existing security controls and monitoring
Prioritize remediation based on impact to business operations and research timelines
Support compliance with HIPAA, FDA guidance, data privacy laws, and contractual security obligations
For biotech organizations, this type of IT security assessment is not just a best practice—it is a practical safeguard for the company’s most valuable assets and its long-term valuation.
Network Penetration Testing Experience in New York Biotech
OCD Tech provides network penetration testing services to organizations in New York City and throughout New York, including biotech startups, established pharmaceutical companies, research labs, and healthcare-adjacent life sciences firms.
Our team combines offensive security expertise (ethical hacking, red team operations, configuration review) with practical IT risk advisory experience. We understand the realities of protecting:
Mixed environments where legacy lab equipment sits beside modern cloud-native systems
Highly privileged researcher accounts with broad access to sensitive data
Shared environments with universities, hospitals, and research partners
Rapidly growing startups scaling their infrastructure faster than their security program
The result is a network penetration test tailored to New York biotech operations—one that not only reveals vulnerabilities, but also provides clear, prioritized remediation guidance aligned with your risk tolerance, regulatory exposure, and growth plans.
Our Network Penetration Testing Methodology
OCD Tech follows a structured, repeatable methodology that mirrors how real-world attackers operate, while staying under strict rules of engagement and regulatory considerations relevant to biotech and healthcare-adjacent environments.
Our typical network penetration test includes:
Passive reconnaissance – Quietly gathering information about your external and internal footprint without direct interaction where possible.
Active reconnaissance – Safely scanning and probing systems to identify open ports, services, and potential attack paths.
Social engineering (optional, in-scope only) – Testing user awareness through controlled phishing or pretexting scenarios, with careful consideration for operational impact.
Exploitation – Attempting to exploit identified weaknesses, misconfigurations, and unpatched systems to gain unauthorized access.
Post-exploitation – Assessing what an attacker could do after initial access: data exposure, system control, and impact on research and clinical operations.
Privilege escalation – Attempting to move from standard user access to administrator or domain-level control.
Lateral movement – Moving through the environment to reach high-value assets such as R&D data stores, LIMS, ELN, and IP repositories.
Maintain access – Demonstrating how an attacker could persist in the network if not detected, while ensuring no backdoors remain after testing.
Cover tracks – Showing how a real attacker may attempt to evade logs and monitoring, while our team fully documents and then restores any changes.
Reporting and executive briefing – Delivering a clear report and debrief that translates technical findings into business, regulatory, and operational risk for biotech leadership.
This approach supports not only traditional red team style offensive testing, but also helps your internal blue team improve detection and response, and can be extended into purple team exercises where we work collaboratively with your security staff.
National Reach
While we focus here on New York City biotech and life sciences organizations, OCD Tech provides network penetration testing and broader cybersecurity services to companies across the United States, including:
This national presence is particularly valuable for biotech companies with multi-site operations, distributed research hubs, or collaborations across multiple metropolitan areas.
Contact Our New York City Network Penetration Testing Consultants
OCD Tech provides network penetration testing, IT security assessments, and cybersecurity consulting to biotech and life sciences organizations in New York City and throughout New York.
If you would like to discuss a network penetration test for your biotech company—whether focused on your corporate network, lab environment, or cloud infrastructure—please complete the form below. A member of our team will follow up to understand your environment, regulatory context, and testing objectives, and then propose an engagement that matches your risk profile and operational needs.
.svg)
.svg)
.svg)
.svg)
.svg)
.svg)
.svg)